For patients who administer high doses of basal insulin (total daily dose exceeding 80 units; >60% of total daily dose) or are at risk of hypoglycemia, consider reducing the dose of basal insulin by 50–75% to minimize risk of hypoglycemia [11]. This evidence concerns the gene INS and Hypoglycemia.